office (916) 927-4400
fax (916) 830-8015
email plriley@sundt.com

News Archive 

organized by newest posts first 

 

A note from the chapter president Judy Roberson:

It's so hopeful for me to follow the happenings at the UC Davis Stem Cell Program. Director, Jan Nolta, PhD, is doing research on Huntington's disease and preparing for a future clinical trial using adult stem cells called MSCs. The GMP Facility has just been completed inside the UC Davis Institute for Regenerative Cures building on the UC Davis Sacramento campus. GMP stands for Good Manufacturing Practices; this facility is the only GMP located in Northern California. Under the direction of Dr. Gerhard Bauer, FDA-grade stem cells will be produced to treat diseases in humans. Learn more about it by clicking on the link below.

http://www.ucdmc.ucdavis.edu/stemcellresearch/





NEW

Hdsa Advocacy

    Nearly everyone affected by HD has trouble obtaining disability benefits.  HDSA is leading a national campaign to address this problem, and we need your help!

A bill in Congress, HR 678, The Huntington’s Disease Parity Act of 2009 would revise the current Social Security Administration (SSA) guidelines for determining disability caused by HD.  It would also eliminate the two-year waiting period to receive Medicare benefits after a disability determination is made by SSA.  If enacted into law, HR 678 would significantly improve the lives of everyone affected by HD.

   

 

Gladstone Institute video on Stem Cell Myths, Truths & Possibilities

Regenerative Medicine at the Gladstone Institute

Stem cell research on neurodegenerative diseases

 

New Videos: Charles Sabine for CHDI, Tim Robbins for HDF and Randy Pausch
                   Stem Cells


Dr. Jan A. Nolta: Professor, Director of the Stem Cell Program and Institute for Regenerative Cures University of California, Davis
shares information on The role of MSC in the treatment of Huntington’s disease:Translation from pre-clinical to clinical




View Recent Photos of our Duck Pluck Event


The Huntington's Disease Parity Act of 2009


Dimebon Phase 3 Trial by Medivation/Pfizer organized by the Huntington Study Group (HSG)


Cogane, a new BDNF inducer, enters the treatment pipeline

 

 

Sustained siRNA production from human MSC to treat Huntington’s Disease
    and other neurodegenerative disorders
- information about California Institute of Regenerative Medicine and the grant given to Dr Jan Nolta

 

 

http://www.usnews.com/articles/science/2009/06/05/huntingtons-disease-protein-may-have-an-accomplice.html

http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/06/05/MN9I180VLD.DTL

http://medheadlines.com/2009/06/05/huntingtons-disease-discovery-called-fabulous-experiment/

http://www.sciencedaily.com/releases/2009/06/090604144330.htm